Wiley Blackwell

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Brennan
    Brennan
  3. Motzer
    Motzer
  4. Shah
    Shah
  5. Danishefsky
    Danishefsky
  6. Russo
    Russo
  7. Shaha
    Shaha
  8. Vickers
    Vickers
  9. Eastham
    Eastham
  10. Scardino
    Scardino

Groups

  1. Department of Medicine (1523)
  2. Surgery (1233)
  3. Solid Tumor Oncology Division (885)
  4. Survivorship Research (814)
  5. GSK Faculty (668)
  6. Population Sciences Research Program (617)
  7. Sloan Kettering Institute Faculty (611)
  8. Department of Pathology and Laboratory Medicine (541)
  9. Epidemiology and Biostatistics (487)
  10. Center for Hematologic Malignancies (434)
Search Within
Formats
  1. Journal Article (3500)
  2. Meeting Abstract (680)
  3. Review (196)
  4. Book Section (106)
  5. Conference Paper (94)
  6. Editorial (90)
  7. Research Letter (35)
  8. Guidelines (27)
  9. Correspondence (25)
  10. Miscellaneous (5)
  11. Book Whole (3)
Groups
  1. Department of Medicine (1523)
  2. Surgery (1233)
  3. Solid Tumor Oncology Division (885)
  4. Survivorship Research (814)
  5. GSK Faculty (668)
  6. Population Sciences Research Program (617)

More Groups

People
  1. Harry Herr (91)
  2. Murray Brennan (86)
  3. Robert Motzer (86)
  4. Jatin Shah (77)
  5. Samuel Danishefsky (74)
  6. Ashok Shaha (71)

More People

Years
  1. 2025 (106)
  2. 2024 (192)
  3. 2023 (261)
  4. 2022 (186)
  5. 2021 (221)
  6. 2020 (183)

More Years

Publications
  1. Cancer (1455)
  2. Journal of Surgical Oncology (373)
  3. BJU International (333)
  4. Hematological Oncology (199)
  5. Histopathology (156)
  6. EMBO Journal (131)

More Publications

Results (4761)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between geriatric impairments and quality of life in older adults with lymphoma on oral targeted therapies: A one‐year prospective study
    Meeting Abstract

    Torka, P.; Akhtar, O.; Kaijar, T.; Wang, K.; Attwood, K.; Carozza, D.; Bouchard, E.; Ghione, P.; Cortese, M.; Wildes, T.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: Update on a COVID era ILROG collaborative report
    Meeting Abstract

    Yang, J.; Gunther, J.; Hajj, C.; Ng, A.; Brady, J. L.; Cheng, S.; Levis, M.; Qi, S.; Mikhaeel, N. G.; Ricardi, U.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiation therapy in the management of primary gastric diffuse large B‐cell lymphomas: Long-term outcomes of 82 patients
    Meeting Abstract

    Fregonese, B.; Schieffelin, L.; Lee, J.; Boe, L.; Imber, B.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Primary hepatic lymphoma: Role of low-dose radiotherapy and paired literature review
    Meeting Abstract

    Ma, J.; Daou, R.; Eid, J. Bou; Lee, J.; Fregonese, B.; El‐Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Figura, N.; Ladbury, C.; Keit, E. R.; Chew, J.; Fregonese, B.; Silverman, E. A.; Hajj, C.; Shah, G.; Kambhampati, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Drug‐resistance mutations in BTK occur in distinct enzymatic classes and are overcome by BTK degradation
    Meeting Abstract

    Montoya, S.; Bourcie, J.; Sondhi, A.; Jahn, J.; Alencar, A.; Abdel-Wahab, O.; Taylor, J.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Functional precision oncology for follicular lymphoma with patient‐derived xenograft in avian embryos
    Meeting Abstract

    Zala, M.; Lipinski, B.; Costechareyre, C.; Jarrosson, L.; Teinturier, R.; Julia, E.; Verney, A.; Guitton, J.; Traverse‐Glehen, A.; Bachy, E.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • MicroRNAs regulate novel signaling pathways targetable by PI3K, MEK, BCL6 and EZH2 inhibitors in ibrutinib resistance mantle cell lymphoma
    Meeting Abstract

    Kersy, O.; Salmon‐Divon, M.; Gomes da Silva, M.; Moita, F.; Cabecadas, J.; Trněný, M.; Basood, M.; Abdel-Wahab, O.; Klener, P.; Shpilberg, O.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • 3‐Year outcomes of adults with relapsed or refractory B‐cell acute lymphoblastic leukemia treated with brexu‐cel in ZUMA‐3 by age, prior therapies, and subsequent transplant
    Meeting Abstract

    Shah, B. D.; Cassaday, R. D.; Park, J. H.; Houot, R.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Leguay, T.; Bishop, M. R.; Topp, M. S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save